Skip to menu Skip to content Skip to footer
Professor

Roslyn Francis

Email: 

Overview

Availability

Professor Roslyn Francis is:
Available for supervision

Works

Search Professor Roslyn Francis’s works on UQ eSpace

99 works between 2006 and 2025

61 - 80 of 99 works

2020

Journal Article

Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study

Hofman, Michael S., Lawrentschuk, Nathan, Francis, Roslyn J., Tang, Colin, Vela, Ian, Thomas, Paul, Rutherford, Natalie, Martin, Jarad M., Frydenberg, Mark, Shakher, Ramdave, Wong, Lih-Ming, Taubman, Kim, Ting Lee, Sze, Hsiao, Edward, Roach, Paul, Nottage, Michelle, Kirkwood, Ian, Hayne, Dickon, Link, Emma, Marusic, Petra, Matera, Anetta, Herschtal, Alan, Iravani, Amir, Hicks, Rodney J., Williams, Scott and Murphy, Declan G. (2020). Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study. The Lancet, 395 (10231), 1208-1216. doi: 10.1016/S0140-6736(20)30314-7

Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study

2020

Journal Article

Baseline and post-treatment 18F-fluorocholine PET/CT predicts outcomes in hepatocellular carcinoma following locoregional therapy

Wallace, Michael C., Sek, Kenny, Francis, Roslyn J., Samuelson, Shaun, Ferguson, John, Tibballs, Jonathan, Asad, Ali, Preen, David B., MacQuillan, Gerry, Garas, George, Adams, Leon A. and Jeffrey, Gary P. (2020). Baseline and post-treatment 18F-fluorocholine PET/CT predicts outcomes in hepatocellular carcinoma following locoregional therapy. Digestive Diseases and Sciences, 65 (2), 647-657. doi: 10.1007/s10620-019-05781-6

Baseline and post-treatment 18F-fluorocholine PET/CT predicts outcomes in hepatocellular carcinoma following locoregional therapy

2019

Journal Article

TheraP: a randomized phase 2 trial of 177Lu-PSMA-617 theranostic treatment vs cabazitaxel in progressive metastatic castration-resistant prostate cancer (Clinical Trial Protocol ANZUP 1603)

Hofman, Michael S., Emmett, Louise, Violet, John, Y. Zhang, Alison, Lawrence, Nicola J., Stockler, Martin, Francis, Roslyn J., Iravani, Amir, Williams, Scott, Azad, Arun, Martin, Andrew, McJannett, Margaret and Davis, Ian D. (2019). TheraP: a randomized phase 2 trial of 177Lu-PSMA-617 theranostic treatment vs cabazitaxel in progressive metastatic castration-resistant prostate cancer (Clinical Trial Protocol ANZUP 1603). BJU International, 124 (S1), 5-13. doi: 10.1111/bju.14876

TheraP: a randomized phase 2 trial of 177Lu-PSMA-617 theranostic treatment vs cabazitaxel in progressive metastatic castration-resistant prostate cancer (Clinical Trial Protocol ANZUP 1603)

2019

Conference Publication

Radiologic Considerations and Standardization of Malignant Pleural Mesothelioma Imaging Within Clinical Trials: Consensus Statement from the NCI Thoracic Malignancy Steering Committee – International Association for the Study of Lung Cancer – Mesothelioma Applied Research Foundation Clinical Trials Planning Meeting

Gill, Ritu R., Tsao, Anne S., Kindler, Hedy L., Richards, William G, Armato, Samuel G., Francis, Roslyn J., Gomez, Daniel R., Dahlberg, Suzanne, Rimner, Andreas, Simone, Charles B., de Perrot, Marc, Blumenthal, Gideon, Adjei, Alex A., Bueno, Raphael, Harpole, David H., Hesdorffer, Mary, Hirsch, Fred R., Pass, Harvey I., Yorke, Ellen, Rosenzweig, Kenneth, Burt, Bryan, Fennell, Dean A., Lindwasser, Wolf, Malik, Shakun, Peikert, Tobias, Mansfield, Aaron S., Salgia, Ravi, Yang, Haining, Rusch, Valerie W. and Nowak, Anna K. (2019). Radiologic Considerations and Standardization of Malignant Pleural Mesothelioma Imaging Within Clinical Trials: Consensus Statement from the NCI Thoracic Malignancy Steering Committee – International Association for the Study of Lung Cancer – Mesothelioma Applied Research Foundation Clinical Trials Planning Meeting. Elsevier Inc. doi: 10.1016/j.jtho.2019.08.012

Radiologic Considerations and Standardization of Malignant Pleural Mesothelioma Imaging Within Clinical Trials: Consensus Statement from the NCI Thoracic Malignancy Steering Committee – International Association for the Study of Lung Cancer – Mesothelioma Applied Research Foundation Clinical Trials Planning Meeting

2019

Conference Publication

Test-Retest Repeatability of 18F-FET PET in Small Volumes

Ferjancic, P., Ebert, M. A., Nowak, A. K., Francis, R. J. and Jeraj, R. (2019). Test-Retest Repeatability of 18F-FET PET in Small Volumes. Annual Meeting of the American-Association-of-Physicists-in-Medicine (AAPM), San Antonio Tx, Jul 14-18, 2019. HOBOKEN: WILEY.

Test-Retest Repeatability of 18F-FET PET in Small Volumes

2019

Journal Article

Imaging in pleural mesothelioma: A review of the 14th International Conference of the International Mesothelioma Interest Group

Armato, Samuel G., Francis, Roslyn J., Katz, Sharyn I., Ak, Guntulu, Opitz, Isabelle, Gudmundsson, Eyjolfur, Blyth, Kevin G. and Gupta, Ashish (2019). Imaging in pleural mesothelioma: A review of the 14th International Conference of the International Mesothelioma Interest Group. Lung Cancer, 130, 108-114. doi: 10.1016/j.lungcan.2018.11.033

Imaging in pleural mesothelioma: A review of the 14th International Conference of the International Mesothelioma Interest Group

2019

Journal Article

Comparison between gallium-68 citrate positron emission tomography-computed tomography and gallium-67 citrate scintigraphy for infection imaging

Segard, Tatiana, Morandeau, Laurence M. J. A., Dunne, Marina L., Robinson, James O., Murray, Ronan J., Geelhoed, Elizabeth A. and Francis, Roslyn J. (2019). Comparison between gallium-68 citrate positron emission tomography-computed tomography and gallium-67 citrate scintigraphy for infection imaging. Internal Medicine Journal, 49 (8), 1016-1022. doi: 10.1111/imj.14231

Comparison between gallium-68 citrate positron emission tomography-computed tomography and gallium-67 citrate scintigraphy for infection imaging

2018

Journal Article

In search of the vulnerable patient or the vulnerable plaque: 18F-sodium fluoride positron emission tomography for cardiovascular risk stratification

Bellinge, Jamie W., Francis, Roslyn J., Majeed, Kamran, Watts, Gerald F. and Schultz, Carl J. (2018). In search of the vulnerable patient or the vulnerable plaque: 18F-sodium fluoride positron emission tomography for cardiovascular risk stratification. Journal of Nuclear Cardiology, 25 (5), 1774-1783. doi: 10.1007/s12350-018-1360-2

In search of the vulnerable patient or the vulnerable plaque: 18F-sodium fluoride positron emission tomography for cardiovascular risk stratification

2018

Journal Article

68Ga-somatostatin analogue PET-CT: Analysis of costs and benefits in a public hospital setting

Segard, Tatiana, Morandeau, Laurence M. J. A., Geelhoed, Elizabeth A and Francis, Roslyn J (2018). 68Ga-somatostatin analogue PET-CT: Analysis of costs and benefits in a public hospital setting. Journal of Medical Imaging and Radiation Oncology, 62 (1), 57-63. doi: 10.1111/1754-9485.12638

68Ga-somatostatin analogue PET-CT: Analysis of costs and benefits in a public hospital setting

2018

Journal Article

The impact of 68 Ga-PSMA PET/CT on management intent in prostate cancer: Results of an australian prospective multicenter study

Roach, Paul J., Francis, Roslyn, Emmett, Louise, Hsiao, Edward, Kneebone, Andrew, Hruby, George, Eade, Thomas, Nguyen, Quoc A., Thompson, Benjamin D., Cusick, Thomas, McCarthy, Michael, Tang, Colin, Ho, Bao, Stricker, Philip D. and Scott, Andrew M. (2018). The impact of 68 Ga-PSMA PET/CT on management intent in prostate cancer: Results of an australian prospective multicenter study . Journal of Nuclear Medicine, 59 (1), 82-88. doi: 10.2967/jnumed.117.197160

The impact of 68 Ga-PSMA PET/CT on management intent in prostate cancer: Results of an australian prospective multicenter study

2017

Conference Publication

Clinical management intent of Ga68 PSMA PET/CT imaging in prostate cancer: an Australian multicentre study

Roach, Paul, Francis, Roslyn, Emmett, Louise, McCarthy, Michael and Scott, Andrew (2017). Clinical management intent of Ga68 PSMA PET/CT imaging in prostate cancer: an Australian multicentre study. Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI), Denver, CO United States, 10-14 June 2017. Reston, VA United States: Society of Nuclear Medicine.

Clinical management intent of Ga68 PSMA PET/CT imaging in prostate cancer: an Australian multicentre study

2017

Conference Publication

ATYPICAL FOR PROSTATE METASTASIS

Culleton, S. and Francis, R. (2017). ATYPICAL FOR PROSTATE METASTASIS. HOBOKEN: WILEY.

ATYPICAL FOR PROSTATE METASTASIS

2017

Conference Publication

A RARE CASE OF MERKEL CELL CARCINOMA CARDIAC METASTASIS CAUSING CARDIAC TAMPONADE: REVIEW OF THE ROLE OF FDG PET IN MERKEL CELL CARCINOMA

Di Loreto, M., Millward, M. and Francis, R. (2017). A RARE CASE OF MERKEL CELL CARCINOMA CARDIAC METASTASIS CAUSING CARDIAC TAMPONADE: REVIEW OF THE ROLE OF FDG PET IN MERKEL CELL CARCINOMA. HOBOKEN: WILEY.

A RARE CASE OF MERKEL CELL CARCINOMA CARDIAC METASTASIS CAUSING CARDIAC TAMPONADE: REVIEW OF THE ROLE OF FDG PET IN MERKEL CELL CARCINOMA

2017

Journal Article

Is FCH PET able to identify foci of infection superiorly to FDG PET?

Hardy, Liesel Elisabeth, Hessamodini, Hannah, Wallace, Michael and Francis, Roslyn (2017). Is FCH PET able to identify foci of infection superiorly to FDG PET?. BMJ Case Reports, 2017 bcr-2017-219944, bcr-2017. doi: 10.1136/bcr-2017-219944

Is FCH PET able to identify foci of infection superiorly to FDG PET?

2016

Journal Article

A pilot study of the utility of choline PET-CT in prostate cancer biochemical relapse following radical prostatectomy

Tan, Hendrick, Joseph, David, Loh, Nelson K., McCarthy, Michael, Leong, Eugene, Siew, Teck, Segard, Tatiana, Morandeau, Laurence, Trevenen, Michelle and Francis, Roslyn J. (2016). A pilot study of the utility of choline PET-CT in prostate cancer biochemical relapse following radical prostatectomy. Journal of Medical Imaging and Radiation Oncology, 60 (3), 374-381. doi: 10.1111/1754-9485.12455

A pilot study of the utility of choline PET-CT in prostate cancer biochemical relapse following radical prostatectomy

2015

Journal Article

A phase 1b clinical trial of the CD40-activating antibody CP-870,893 in combination with cisplatin and pemetrexed in malignant pleural mesothelioma

Nowak, A. K., Cook, A. M., McDonnell, A. M., Millward, M. J., Creaney, J., Francis, R. J., Hasani, A., Segal, A., Musk, A. W., Turlach, B. A., McCoy, M. J., Robinson, B. W.S. and Lake, R. A. (2015). A phase 1b clinical trial of the CD40-activating antibody CP-870,893 in combination with cisplatin and pemetrexed in malignant pleural mesothelioma. Annals of Oncology, 26 (12), 2483-2490. doi: 10.1093/annonc/mdv387

A phase 1b clinical trial of the CD40-activating antibody CP-870,893 in combination with cisplatin and pemetrexed in malignant pleural mesothelioma

2015

Journal Article

Characterization of hypoxia in malignant pleural mesothelioma with FMISO PET-CT

Francis, Roslyn J., Segard, Tatiana, Morandeau, Laurence, Lee, Y.C. Gary, Millward, Michael J., Segal, Amanda and Nowak, Anna K. (2015). Characterization of hypoxia in malignant pleural mesothelioma with FMISO PET-CT. Lung Cancer, 90 (1), 55-60. doi: 10.1016/j.lungcan.2015.07.015

Characterization of hypoxia in malignant pleural mesothelioma with FMISO PET-CT

2015

Journal Article

A multicentre comparison of quantitative 90Y PET/CT for dosimetric purposes after radioembolization with resin microspheres: The QUEST Phantom Study

Willowson, Kathy P., Tapner, Michael, The QUEST Investigator Team, , Bailey, Dale L., Willowson, K. P., Tapner, M. J., Ahmadzadehfar, H., Amthauer, H., Großer, O. S., Arbizu, J., Martí-Climent, J. M., Rodriguez-Fraile, M., Attarwala, A. A., Glatting, G., Molina-Duran, F., Bagni, O., Filippi, L., Benard, F., Celler, A., Bonutti, F., Botta, F., Ferrari, M., Boucek, J. A., Francis, R., Bourgeois, A. C., Bradley, Y. C., Pasciak, A. S., Buchholz, H. G., Miederer, M. ... Yu, N. (2015). A multicentre comparison of quantitative 90Y PET/CT for dosimetric purposes after radioembolization with resin microspheres: The QUEST Phantom Study. European Journal of Nuclear Medicine and Molecular Imaging, 42 (8), 1202-1222. doi: 10.1007/s00259-015-3059-9

A multicentre comparison of quantitative 90Y PET/CT for dosimetric purposes after radioembolization with resin microspheres: The QUEST Phantom Study

2014

Conference Publication

Characterization of the effect of pleurodesis on FLT and FDG PET/CT imaging in malignant pleural mesothelioma (MPM)

Francis, Roslyn, Nowak, Anna, Segard, Tatiana, Morandeau, Laurence, Lee, Gary, Boucek, Jan and Millward, Michael (2014). Characterization of the effect of pleurodesis on FLT and FDG PET/CT imaging in malignant pleural mesothelioma (MPM). Annual Meeting of the Society-of-Nuclear-Medicine-and-Molecular-Imaging (SNMMI), St Louis Mo, Jun 07-11, 2014. RESTON: SOC NUCLEAR MEDICINE INC.

Characterization of the effect of pleurodesis on FLT and FDG PET/CT imaging in malignant pleural mesothelioma (MPM)

2014

Journal Article

Observer variability in mesothelioma tumor thickness measurements: Defining minimally measurable lesions

Armato III, Samuel G., Nowak, Anna K., Francis, Roslyn J., Kocherginsky, Masha and Byrne, Michael J. (2014). Observer variability in mesothelioma tumor thickness measurements: Defining minimally measurable lesions. Journal of Thoracic Oncology, 9 (8), 1187-1194. doi: 10.1097/JTO.0000000000000211

Observer variability in mesothelioma tumor thickness measurements: Defining minimally measurable lesions

Funding

Current funding

  • 2020 - 2026
    A new radio-imaging agent to guide targeted therapy for epithelial ovarian cancer
    NHMRC MRFF EPCDR - Ovarian Cancer Research
    Open grant

Supervision

Availability

Professor Roslyn Francis is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Media

Enquiries

For media enquiries about Professor Roslyn Francis's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au